T 0056/23 vom 14.01.2025
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2025:T005623.20250114
- Datum der Entscheidung
- 14. Januar 2025
- Aktenzeichen
- T 0056/23
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 18210706.0
- IPC-Klasse
- A61F 2/24
- Verfahrenssprache
- Englisch
- Verteilung
- Nicht verteilt (D)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- PROSTHETIC HEART VALVE
- Name des Antragstellers
- Edwards Lifesciences Corporation
- Name des Einsprechenden
- 1. Meril GmbH
2. Abbott Cardiovascular Systems, Inc. - Kammer
- 3.2.01
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 56European Patent Convention Art 76(1)Rules of procedure of the Boards of Appeal 2020 Art 011Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Schlagwörter
- Divisional application - subject-matter extends beyond content of earlier application (yes)
Inventive step - common general knowledge
Inventive step - obvious combination of known features
Amendment after notification of Art. 15(1) RPBA communication: Auxiliary request 67
Amendment after notification of Art. 15(1) RPBA communication - exceptional circumstances (yes)
Amendment after notification of Art. 15(1) RPBA communication - taken into account (yes)
Amendment after notification of Art. 15(1) RPBA communication - Auxiliary request 73
Amendment after notification of Art. 15(1) RPBA communication - exceptional circumstances (no)
Amendment after notification of Art. 15(1) RPBA communication - taken into account (no)
Remittal - special reasons for remittal (no) - Orientierungssatz
- -
- Zitierte Akten
- T 0247/20
- Zitierende Akten
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked